FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088191642> ?p ?o ?g. }

• W2088191642 endingPage "67" @default.
• W2088191642 startingPage "61" @default.
• W2088191642 abstract "Abstract. Purpose: To compare the outcomes of treatment with intravitreal bevacizumab alone (BEVA group) or in combination with photodynamic therapy (PDT) (COMB group), in patients aged at least 50 years with neovascular maculopathy. Methods: Forty‐one patients with neovascular age‐related macular degeneration (AMD) ( n = 31) or polypoidal choroidal vasculopathy (PCV) ( n = 10) were randomized to either the BEVA group ( n = 18) or the COMB group ( n = 23). A total of three intravitreal bevacizumab injections (1.25 mg/0.05 ml) were given at 6‐week intervals. In the COMB group, PDT was included near the time of one injection. Patients underwent best‐corrected visual acuity (BCVA) measurement and optical coherence tomography (OCT) at every visit. Fluorescein angiography and indocyanine green angiography were repeated every 3 months. Results: Overall BCVA (p = 0.001) and central foveal thickness (CFT) (p < 0.001) measured by OCT improved significantly at 12 months, and there was no between‐group difference in BCVA or CFT between the BEVA and COMB groups. Whereas AMD patients showed significant improvement in BCVA (p = 0.001) and CFT (p = 0.004), PCV patients failed to improve. The effect of bevacizumab alone on neovascular AMD was similar to that of combination therapy, when measured by both BCVA and CFT. The total number of bevacizumab injections was not reduced when PDT was given, either among all patients or in a subgroup of naïve patients (p > 0.05). No serious complication was noted. Conclusion: The results of our 12‐month prospective study indicate that intravitreal bevacizumab alone has similar efficacy and safety to bevacizumab plus PDT for treatment of patients with neovascular AMD, even treatment‐naïve patients. The addition of PDT did not assist in reducing the required total number of bevacizumab injections." @default.
• W2088191642 created "2016-06-24" @default.
• W2088191642 creator A5006684327 @default.
• W2088191642 creator A5009494138 @default.
• W2088191642 creator A5011227177 @default.
• W2088191642 creator A5044685974 @default.
• W2088191642 creator A5048382900 @default.
• W2088191642 creator A5083290759 @default.
• W2088191642 date "2012-01-30" @default.
• W2088191642 modified "2023-10-18" @default.
• W2088191642 title "Intravitreal bevacizumab alone versus in combination with photodynamic therapy for the treatment of neovascular maculopathy in patients aged 50 years or older: 1-year results of a prospective clinical study" @default.
• W2088191642 cites W1487528435 @default.
• W2088191642 cites W1768895213 @default.
• W2088191642 cites W1963735411 @default.
• W2088191642 cites W1968609549 @default.
• W2088191642 cites W1981608508 @default.
• W2088191642 cites W1995708259 @default.
• W2088191642 cites W2021496037 @default.
• W2088191642 cites W2023523208 @default.
• W2088191642 cites W2026165074 @default.
• W2088191642 cites W2030500051 @default.
• W2088191642 cites W2033245558 @default.
• W2088191642 cites W2039446733 @default.
• W2088191642 cites W2055522471 @default.
• W2088191642 cites W2062478098 @default.
• W2088191642 cites W2080591818 @default.
• W2088191642 cites W2098104317 @default.
• W2088191642 cites W2165066800 @default.
• W2088191642 cites W2167535056 @default.
• W2088191642 cites W2233259956 @default.
• W2088191642 doi "https://doi.org/10.1111/j.1755-3768.2009.01841.x" @default.
• W2088191642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20337606" @default.
• W2088191642 hasPublicationYear "2012" @default.
• W2088191642 type Work @default.
• W2088191642 sameAs 2088191642 @default.
• W2088191642 citedByCount "29" @default.
• W2088191642 countsByYear W20881916422012 @default.
• W2088191642 countsByYear W20881916422013 @default.
• W2088191642 countsByYear W20881916422014 @default.
• W2088191642 countsByYear W20881916422015 @default.
• W2088191642 countsByYear W20881916422016 @default.
• W2088191642 countsByYear W20881916422017 @default.
• W2088191642 countsByYear W20881916422018 @default.
• W2088191642 countsByYear W20881916422019 @default.
• W2088191642 countsByYear W20881916422021 @default.
• W2088191642 countsByYear W20881916422022 @default.
• W2088191642 crossrefType "journal-article" @default.
• W2088191642 hasAuthorship W2088191642A5006684327 @default.
• W2088191642 hasAuthorship W2088191642A5009494138 @default.
• W2088191642 hasAuthorship W2088191642A5011227177 @default.
• W2088191642 hasAuthorship W2088191642A5044685974 @default.
• W2088191642 hasAuthorship W2088191642A5048382900 @default.
• W2088191642 hasAuthorship W2088191642A5083290759 @default.
• W2088191642 hasBestOaLocation W20881916421 @default.
• W2088191642 hasConcept C118487528 @default.
• W2088191642 hasConcept C134018914 @default.
• W2088191642 hasConcept C141071460 @default.
• W2088191642 hasConcept C178790620 @default.
• W2088191642 hasConcept C185592680 @default.
• W2088191642 hasConcept C188816634 @default.
• W2088191642 hasConcept C2776403814 @default.
• W2088191642 hasConcept C2776694085 @default.
• W2088191642 hasConcept C2777802072 @default.
• W2088191642 hasConcept C2778257484 @default.
• W2088191642 hasConcept C2778313320 @default.
• W2088191642 hasConcept C2780248432 @default.
• W2088191642 hasConcept C2781116099 @default.
• W2088191642 hasConcept C2781148688 @default.
• W2088191642 hasConcept C2781323092 @default.
• W2088191642 hasConcept C2781359195 @default.
• W2088191642 hasConcept C555293320 @default.
• W2088191642 hasConcept C71924100 @default.
• W2088191642 hasConceptScore W2088191642C118487528 @default.
• W2088191642 hasConceptScore W2088191642C134018914 @default.
• W2088191642 hasConceptScore W2088191642C141071460 @default.
• W2088191642 hasConceptScore W2088191642C178790620 @default.
• W2088191642 hasConceptScore W2088191642C185592680 @default.
• W2088191642 hasConceptScore W2088191642C188816634 @default.
• W2088191642 hasConceptScore W2088191642C2776403814 @default.
• W2088191642 hasConceptScore W2088191642C2776694085 @default.
• W2088191642 hasConceptScore W2088191642C2777802072 @default.
• W2088191642 hasConceptScore W2088191642C2778257484 @default.
• W2088191642 hasConceptScore W2088191642C2778313320 @default.
• W2088191642 hasConceptScore W2088191642C2780248432 @default.
• W2088191642 hasConceptScore W2088191642C2781116099 @default.
• W2088191642 hasConceptScore W2088191642C2781148688 @default.
• W2088191642 hasConceptScore W2088191642C2781323092 @default.
• W2088191642 hasConceptScore W2088191642C2781359195 @default.
• W2088191642 hasConceptScore W2088191642C555293320 @default.
• W2088191642 hasConceptScore W2088191642C71924100 @default.
• W2088191642 hasIssue "1" @default.
• W2088191642 hasLocation W20881916421 @default.
• W2088191642 hasLocation W20881916422 @default.
• W2088191642 hasOpenAccess W2088191642 @default.
• W2088191642 hasPrimaryLocation W20881916421 @default.
• W2088191642 hasRelatedWork W1974254805 @default.
• W2088191642 hasRelatedWork W2009955989 @default.
• W2088191642 hasRelatedWork W2085712747 @default.

• next